Results of Auspex Pharmaceuticals' Phase 3 Registration Trial of SD-809 to be Presented at AAN Annual Meeting
March 27, 2015 at 07:02 AM EDT
Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late-clinical stage biopharmaceutical company dedicated to developing innovative ...